NCT06627270View on ClinicalTrials.gov

Antibiotic Treatment Effects on Intratumoral Bacteria Modulation in Surgical Patients With Oral Cancer

PHASE2RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 11, 2025

Primary Completion Date

October 1, 2026

Study Completion Date

October 1, 2027

Conditions
Oral Squamous Cell CarcinomaOral CancerHead and Neck CancerHead and Neck Carcinoma
Interventions
DRUG

Metronidazole

Participants will receive metronidazole (500 mg t.i.d. x 10 days)

OTHER

Chlorhexidine

Mouth rinse chlorhexidine (10 ml t.i.d. x 10 days)

Trial Locations (1)

44195

RECRUITING

Case Comprehensive Cancer Center, Cleveland Clinic Foundation, Cleveland

All Listed Sponsors
lead

Case Comprehensive Cancer Center

OTHER